ACE2 and Kallmann syndrome: Many brain structures exhibited a high expression of ACE2 including the olfactory bulb, a region that has been associated with anosmia (loss of smell sense), a recurrent symptom also reported by patients with COVID-19 (Chen et al., 2021).